Xi'an ruixi Biological Technology Co

Home > Keywords >

Catalog	name	Description	price
R-CG-083	Silica coated mesoporous Fe3O4	Mesoporous materials are conducive to the storage and control of drug release, and can achieve targeted drug release. Ferric oxide (Fe_ 3O_ 4) It is the only metal oxide approved by FDA for biomedical application. Using mesoporous Fe_ 3O_ Magnetic nanoparticles are used as drug carriers to load drug mesoporous Fe by applying an external magnetic field_ 3O_ Nanoparticles can selectively act on specific physiological parts, organs, tissues or cells, and exert drug efficacy in these parts, so as to reduce the dosage and "burst release" of drugs, improve the efficiency of drug treatment, and reduce the toxic and side effects of drugs.	price>
R-M-764	Dansyl-D-Ala-Gly-4-nitro-Phe-Gly-OH trifluoroacetate salt	Highly sensitive fluorescence resonance energy transfer (FRET) substrate for neutral endopeptidase (NEP or neprilysin EC 3.4.24.11) (Km = 45 μM, kcat = 59 min⁻¹, kcat/Km = 1.3 min⁻¹μM⁻¹). Enzymatic activity can be monitored with an excitation wavelength of 342 nm and an emission wavelength of 562 nm.	price>
R-R-1913	AZD5582 dihydrochloride CAS No.1883545-51-4	AZD5582 dihydrochloride/CAS No.1883545-51-4 is an antagonist of the inhibitor of apoptosis proteins (IAPs), which binds to the BIR3 domains cIAP1, cIAP2, and XIAP with IC50s of 15, 21, and 15 nM, respectively. AZD5582 induces apoptosis.	price>
R-CG-084	peg coated mesoporous Fe3O4	poly(ethylene glycol) coated mesoporous Fe3O4，peg coated mesoporous Fe3O4 from ruixi.Mesoporous materials are conducive to the storage and control of drug release, and can achieve targeted drug release. Ferric oxide (Fe_ 3O_ 4) It is the only metal oxide approved by FDA for biomedical application. Using mesoporous Fe_ 3O_ Magnetic nanoparticles are used as drug carriers to load drug mesoporous Fe by applying an external magnetic field_ 3O_ Nanoparticles can selectively act on specific physiological parts, organs, tissues or cells, and exert drug efficacy in these parts, so as to reduce the dosage and "burst release" of drugs, improve the efficiency of drug treatment, and reduce the toxic and side effects of drugs	price>
R-M-765	Calcitonin (8-32) (salmon I) trifluoroacetate salt	Calcitonin (8-32) (salmon I) has been been proposed as an amylin receptor antagonist which is highly selective for amylin. sCT 8-32 reverses the inhibitory effect of amylin on glucose-induced insulin release and potentiates the insulin response to glucose in the rat perfused pancreas.	price>
R-R-1914	12-HETE CAS No.71030-37-0	12-HETE/CAS No.71030-37-0, a major metabolic product of arachidonic acid using 12-LOX catalysis, inhibits cell apoptosis in a dose-dependent manner. 12-HETE promotes the activation and nuclear translocation of NF-κB through the integrin-linked kinase (ILK) pathway.12-HETE has both anti-thrombotic and pro-thrombotic effects. 12-HETE is a neuromodulator.	price>
R-CG-085	peg-NH2 coated mesoporous Fe3O4,Amine(NH2)function	peg-NH2 coated mesoporous Fe3O4,Amine(NH2)function,peg-NH2 coated mesoporous Fe3O4，Amine(NH2)function from ruixi.Mesoporous materials are conducive to the storage and control of drug release, and can achieve targeted drug release. Ferric oxide (Fe_ 3O_ 4) It is the only metal oxide approved by FDA for biomedical application. Using mesoporous Fe_ 3O_ Magnetic nanoparticles are used as drug carriers to load drug mesoporous Fe by applying an external magnetic field_ 3O_ Nanoparticles can selectively act on specific physiological parts, organs, tissues or cells, and exert drug efficacy in these parts, so as to reduce the dosage and "burst release" of drugs, improve the efficiency of drug treatment, and reduce the toxic and side effects of drugs.	price>
R-M-766	Calcitonin C-Terminal Flanking Peptide (human) trifluoroacetate salt	Calcitonin C-Terminal Flanking Peptide (human) trifluoroacetate salt,Katacalcin is a potent plasma calcium-lowering peptide, also called C-procalcitonin or PDN-21, flanks calcitonin on the C-terminal side within the human calcitonin precursor. Katacalcin specifically binds to the calcitonin receptor of CD14⁺ peripheral blood mononuclear cells.	price>
R-R-1915	Apostatin-1 CAS No.2559703-06-7	Apostatin-1 (Apt-1)/CAS No.2559703-06-7 is a potent TRADD inhibitor. Apostatin-1 can bind with TRADD-N (KD=2.17 μM), disrupting its binding to both TRADD-C and TRAF2. Apostatin-1 modulates the ubiquitination of RIPK1 and beclin 1. Apostatin-1 blocks apoptosis and restores cellular homeostasis by activating autophagy in cells with accumulated mutant tau, α-synuclein, or huntingtin.	price>
R-CG-086	peg-cooh coated mesoporous Fe3O4,carboxyl function	poly(ethylene glycol)-carboxyl coated mesoporous Fe3O4,carboxyl function,peg-cooh coated mesoporous Fe3O4,carboxyl function from ruixi.Mesoporous materials are conducive to the storage and control of drug release, and can achieve targeted drug release. Ferric oxide (Fe_ 3O_ 4) It is the only metal oxide approved by FDA for biomedical application. Using mesoporous Fe_ 3O_ Magnetic nanoparticles are used as drug carriers to load drug mesoporous Fe by applying an external magnetic field_ 3O_ Nanoparticles can selectively act on specific physiological parts, organs, tissues or cells, and exert drug efficacy in these parts, so as to reduce the dosage and "burst release" of drugs, improve the efficiency of drug treatment, and reduce the toxic and side effects of drugs.	price>
R-M-767	Calcitonin N-Terminal Flanking Peptide (human)	Calcitonin N-Terminal Flanking Peptide (human),CAS: 118277-01-3 from ruixi.Synthetic N-procalcitonin (N-PCT) has been shown to stimulate proliferation of normal and neoplastic human osteoblasts at nanomolar concentrations. Tavares et al. have demonstrated that intracerebroventricular administration of N-PCT significantly decreased food intake and body weight gain for at least 48 h in conscious, freely moving, and unstressed rats fed ad libitum.	price>
R-R-1916	Lometrexol disodium CAS No.120408-07-3	Lometrexol (DDATHF) disodium/CAS No.120408-07-3, an antipurine antifolate, can inhibit the activity of glycinamide ribonucleotide formyltransferase (GARFT) but do not induce detectable levels of DNA strand breaks. Lometrexol disodium can further inhibit de novo purine synthesis, causing abnormal cell proliferation and apoptosis, even cell cycle arrest. Lometrexol disodium has anticancer activity. Lometrexol disodium also is a potent human Serine hydroxymethyltransferase1/2 (hSHMT1/2) inhibitor.	price>
R-SA-001	Streptavidin(SA)-PEG-PLGA	Streptavidin-poly(ethylene glycol)-Poly(lactic-co-glycolic acid),Streptavidin(SA)-PEG-PLGA,PLGA-PEG-Streptavidin(SA),PLGA-SA from ruixi.Streptavidin is a biotin binding protein derived from Streptomyces avidinii. Its nonspecific binding is much lower than that of avidini. Streptavidin protein has more favorable chemical properties such as almost no net charge at neutral pH and no carbohydrate. Therefore, it is widely used as an alternative to avidini. Sa-peg-plga is a customized product. Ruixi can also customize other binding products of streptavidin.	price>
R-M-768	Calcium-Like Peptide 3 trifluoroacetate salt	CALP-3(Calcium-Like Peptide 3 trifluoroacetate salt), VKFGVGFK, acts as a calmodulin agonist. The octapeptide interacts with the calmodulin EF-hand motif, the Ca²⁺-binding site. CALP-3 activates phosphodiesterase in the absence of calcium and inhibits Ca²⁺-mediated cytotoxicity and apoptosis. CALP-3 is more active than CALP-1. By preventing trypsin activation within pancreatiic acinar cells CALP-3 shows potential therapeutic potential in the treatment of pancreatitis.	price>
R-R-1917	Furanodienone CAS No.24268-41-5	Furanodienone/CAS No.24268-41-5 is one of the major bioactive constituents derived from Rhizoma Curcumae. Furanodienone induced apoptosis.	price>
R-SA-002	Streptavidin(SA)-PEG-PCL	Streptavidin-poly(ethylene glycol)-Poly(ε-caprolactone),Streptavidin(SA)-PEG-PCL,PCL-PEG-Streptavidin(SA),PCL-SA from ruixi.Streptavidin is a biotin binding protein derived from Streptomyces avidinii. Its nonspecific binding is much lower than that of avidini. Streptavidin protein has more favorable chemical properties such as almost no net charge at neutral pH and no carbohydrate. Therefore, it is widely used as an alternative to avidini. Sa-peg-PCL is a customized product. Ruixi can also customize other binding products of streptavidin.	price>
R-M-769	Amyloid β-Protein (1-40) (HFIP-treated)	Amyloid β-Protein (1-40) (HFIP-treated),CAS :131438-79-4 is a Amyloid peptide.It can be used Alzheimer Disease.	price>
R-R-1918	GLUT4-IN-2 CAS No.2454113-83-6	GLUT4-IN-2/CAS No.2454113-83-6 is a potent and selective GLUT4 inhibitor with IC50s of 11.4 µM and 6.8 µM for GLUT1 and GLUT4, respectively. GLUT4-IN-2 induces cell apoptosis and cell cycle arrest at G0/G1phase. GLUT4-IN-2 shows potent antitumor activity.	price>
R-SA-003	Streptavidin(SA)-PEG-PLA	Streptavidin-poly(ethylene glycol)-Poly(D,L-lactide)，Streptavidin(SA)-PEG-PLA，PLA-PEG-Streptavidin(SA) ,PLA-SAfrom ruixi.Streptavidin is a biotin binding protein derived from Streptomyces avidinii. Its nonspecific binding is much lower than that of avidini. Streptavidin protein has more favorable chemical properties such as almost no net charge at neutral pH and no carbohydrate. Therefore, it is widely used as an alternative to avidini. Sa-peg-PLA is a customized product. Ruixi can also customize other binding products of streptavidin.	price>
R-M-770	Amyloid β-Protein (1-40) trifluoroacetate salt	Amyloid β-peptide (1-40) showed both neurotrophic and neurotoxic effects in dependence on the neuronal age and the concentration of the β-protein. Aβ 1-40 has been used as well as Aβ 1-42 to detect amyloid β-protein multimers in the cerebrospinal fluid of Alzheimer disease patients.	price>

384385386387388389 390391392393394